Proliferation and migration of vascular smooth muscle cells (VSMCs) play pivotal roles in the development of restenosis after angioplasty and oxidative stress involves both processes. Naringenin, a flavanone compound found in citrus fruits, has been widely evaluated for antioxidant activity. This study was designed to explore whether naringenin could inhibit angiotensin II-induced VSMCs proliferation and migration and decrease neointimal hyperplasia in balloon injured rat carotid arteries. VSMCs were treated with or without naringenin before stimulation with 1 µM angiotensin II and twenty-four rats were subjected to carotid arteries injury and the carotid arteries were harvested at 14 d after balloon injury. The results showed naringenin led to a significant inhibition of angiotensin II-induced VSMCs proliferation and migration. Naringenin significantly attenuated the reactive oxygen species production, increased the superoxide dismutase activity and decreased the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, reduced phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and p38 mitogen-activated protein kinase (MAPK) and the nuclear translocation of nuclear factor (NF)-κB p65 in angiotensin II-treated VSMCs. Moreover, naringenin decreased the ratio of neointima to media by 63.8% in balloon injured rat carotid arteries, and the serum level of 8-iso-prostaglandin F2α in naringenin-treated rats was significantly decreased. These results indicated naringenin exhibited antioxidant activity on angiotensin II-treated VSMCs and balloon injured rat carotid arteries and could be a potential protective agent for restenosis after angioplasty.Key words naringenin; vascular smooth muscle cell; oxidative stress; neointimal hyperplasia; angiotensin II Coronary heart disease (CHD) remains the leading cause of mortality in most developed countries and many developing countries.1,2) Percutaneous coronary intervention with or without intracoronary stent placement is widely used for treatment of symptomatic CHD and has greatly improved the survival rate.3,4) However, restenosis after angioplasty, which happen in 5-10% patients, is still a major clinical problem. 5,6) Studies have shown that abnormal proliferation and migration of vascular smooth muscle cells (VSMCs) play pivotal roles in the development of restenosis after angioplasty, as well as in atherosclerosis.7-9) Inhibition of proliferation and migration of VSMCs could remarkably attenuate the neointimal hyperplasia in animal studies.
10-12)Naringenin, a flavanone compound found in citrus fruits, such as oranges and grapes, 13) has been pharmacologically evaluated for antioxidant activity.14,15) Although some studies showed that naringenin could inhibit VSMCs proliferation and migration in vitro, 16,17) the effect and mechanism of naringenin on vascular injury are still far from clear. In this investigation, we attempted to evaluate whether naringenin could inhibit angiotensin II-induced VSMCs proliferation and migration in vitro a...